Apoptosis provoked by the oxidative stress inducer menadione (vitamin K3) is mediated by the Fas/Fas ligand system

被引:42
作者
Caricchio, R
Kovalenko, D
Kaufmann, WK
Cohen, PL
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27514 USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol Immunol, Chapel Hill, NC 27514 USA
[3] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pathol, Chapel Hill, NC 27514 USA
[4] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Lab Med, Chapel Hill, NC 27514 USA
关键词
menadione; Fas; apoptosis; oxidative stress; lymphocytes;
D O I
10.1006/clim.1999.4757
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Menadione, or vitamin K-3 (VK3), a potent oxidative stress inducer, has been recently used as an effective and remarkably safe cytotoxic drug for treatment of several human tumors. VK3 induces apoptotic cell death through a poorly understood mechanism. Here we show for the first time that VK3-induced apoptosis requires the Fas/FasL system. Spleen cells from both Fas- and FasL-deficient mice (C57BL/6-lpr and C57BL/ 6-gld, respectively) had much lower levels of VK, apoptosis in vitro compared to cells from control C57BL/6 mice. VK3 cytotoxicity toward mouse splenocytes was also blocked with a Fas-Fc fusion protein. VK3 induced apoptosis in Jurkat cells, coincident with an increase in both Fas and Fast expression. A Fast-resistant variant of these Jurkat cells was also resistant to VK3-induced apoptosis. Furthermore, because VK3 effects were inhibited by glutathione, a potent antioxidant, oxidative stress was linked to the Fas/FasL system. Moreover, since the Jurkat cell lines were p53 null, the activation of Fas/FasL system after oxidative stress apparently acted through a p53-independent pathway. The therapeutic relevance of the K vitamins has been growing in recent years; our findings offer new insight for improving and expanding their applications. (C) 1999 Academic Press.
引用
收藏
页码:65 / 74
页数:10
相关论文
共 53 条
  • [1] FUNCTIONAL MYC-MAX HETERODIMER IS REQUIRED FOR ACTIVATION-INDUCED APOPTOSIS IN T-CELL HYBRIDOMAS
    BISSONNETTE, RP
    MCGAHON, A
    MAHBOUBI, A
    GREEN, DR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) : 2413 - 2418
  • [2] CELL-AUTONOMOUS FAS (CD95) FAS-LIGAND INTERACTION MEDIATES ACTIVATION-INDUCED APOPTOSIS IN T-CELL HYBRIDOMAS
    BRUNNER, T
    MOGIL, RJ
    LAFACE, D
    YOO, NJ
    MAHBOUBI, A
    ECHEVERRI, F
    MARTIN, SJ
    FORCE, WR
    LYNCH, DH
    WARE, CF
    GREEN, DR
    [J]. NATURE, 1995, 373 (6513) : 441 - 444
  • [3] COMPARISON OF THE VITAMIN-K1, VITAMIN-K2 AND VITAMIN-K3 AS COFACTORS FOR THE HEPATIC VITAMIN-K-DEPENDENT CARBOXYLASE
    BUITENHUIS, HC
    SOUTE, BAM
    VERMEER, C
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1034 (02) : 170 - 175
  • [4] Caricchio R, 1998, J IMMUNOL, V161, P241
  • [5] Chinnaiyan AM, 1996, CURR BIOL, V6, P555
  • [6] Cohen JJ, 1996, ADV EXP MED BIOL, V406, P11
  • [7] Cohen Philip L., 1995, P169
  • [8] Thiol-mediated inhibition of FAS and CD2 apoptotic signaling in activated human peripheral T cells
    Deas, O
    Dumont, C
    Mollereau, B
    Metivier, D
    Pasquier, C
    BernardPomier, G
    Hirsch, F
    Charpentier, B
    Senik, A
    [J]. INTERNATIONAL IMMUNOLOGY, 1997, 9 (01) : 117 - 125
  • [9] Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain
    Dowling, P
    Shang, GF
    Raval, S
    Menonna, J
    Cook, S
    Husar, W
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04) : 1513 - 1518
  • [10] INDUCTION OF APOPTOSIS IN FIBROBLASTS BY C-MYC PROTEIN
    EVAN, GI
    WYLLIE, AH
    GILBERT, CS
    LITTLEWOOD, TD
    LAND, H
    BROOKS, M
    WATERS, CM
    PENN, LZ
    HANCOCK, DC
    [J]. CELL, 1992, 69 (01) : 119 - 128